PhD. student
Mgr. Pavol Boďo
National
Current
- Aldo-keto reductase inhibitors in the personalized therapy of several types of cancerProgram: VEGADuration: 1. 1. 2022 – 31. 12. 2025
- Development of multifunctional aldose reductase inhibitors based on triazinoindoles: Optimization of their biological activity, selectivity, bioavailability and antioxidant properties.Program: VEGADuration: 1. 1. 2022 – 31. 12. 2025
- Multi-target approach to diverse molecular mechanisms of diabetic complications and other glucose toxicity related diseasesProgram: SRDADuration: 1. 8. 2021 – 30. 6. 2025
- Gut microbiota and diabetic peripheral neuropathy: effect of cemtirestat in rat models of diabetesProgram: SRDADuration: 1. 7. 2020 – 30. 6. 2024